Canadian Hemophilia Society -

Title

Access to Innovative and Curatives Therapies – NRBDO virtual conference
CHS/SCH | 27/10/2020
NOVEMBER 5-7 Many innovative and curative therapies are coming to market for rare blood disorders, but will they be available to Canadian patients? What is the role of patient...

CHS inhibitor videoconference
CHS/SCH | 20/10/2020
On Monday, November 2, from 7 p.m. to 8:30 p.m. ET, the CHS will be hosting a live educational videoconference, aimed at improving understanding of FVIII/ FIX inhibitors and...

COVID-19 updates
CHS/SCH | 14/10/2020
Access the most updated information regarding COVID-19 and inherited bleeding disorders: www.hemophilia.ca/covid-19

The Perfect Fit – Tailoring hemophilia A management to each unique patient
CHS/SCH | 06/10/2020
Chapters of the CHS would like to invite you to a special webinar intended for Canadian patients and caregivers only. The learning objectives are: Overview of current treatment approaches...

Features
- CHS/SCH | 06/10/2020
  WFH Advisory: availability of desmopressin
- CHS/SCH | 23/09/2020
  Products in the pipeline
- CHS/SCH | 09/09/2020
  Coagulation products
- David Page | 02/09/2020
  WFH publishes 3rd Edition of the Guidelines for the Management of Hemophilia
- David Page | 01/09/2020
  FDA denies approval of Biomarin’s FVIII gene therapy
- Kathy Lawday | 12/08/2020
  Management of comorbidities in bleeding disorders
- Kathy Lawday | 12/08/2020
  Substitution therapy
- CHS/SCH | 06/08/2020
  Plasma Saves Lives: Addressing the COVID-19 Pandemic

INNOVATORS

BUILDER

Believers